Australia markets closed

X4 Pharmaceuticals, Inc. (XFOR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1500+0.0700 (+6.48%)
At close: 04:00PM EDT
1.1400 -0.01 (-0.87%)
After hours: 07:30PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
99,216
121,718
81,787
78,708
Other short-term investments
15,000
0
-
-
Total cash
114,216
121,718
81,787
78,708
Other current assets
7,298
5,807
5,344
3,682
Total current assets
122,076
128,677
87,878
83,307
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
8,014
9,561
10,948
9,471
Accumulated depreciation
-1,619
-1,228
-724
-274
Net property, plant and equipment
6,395
8,333
10,224
9,197
Goodwill
17,351
17,351
17,351
27,109
Other long-term assets
1,436
1,225
1,723
3,258
Total non-current assets
25,182
26,909
29,298
39,564
Total assets
147,258
155,586
117,176
122,871
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
1,315
795
-
Accounts payable
8,947
7,777
4,283
3,144
Accrued liabilities
4,621
5,442
2,453
4,262
Total current liabilities
22,862
22,324
14,023
11,948
Non-current liabilities
Long-term debt
54,570
32,304
33,139
33,178
Other long-term liabilities
432
173
826
462
Total non-current liabilities
73,297
59,211
38,741
38,124
Total liabilities
96,159
81,535
52,764
50,072
Stockholders' equity
Common stock
167
122
28
16
Retained earnings
-477,905
-376,738
-282,871
-194,175
Accumulated other comprehensive income
-119
-119
-119
-119
Total stockholders' equity
51,099
74,051
64,412
72,799
Total liabilities and stockholders' equity
147,258
155,586
117,176
122,871